ArchivesMagazine - 05 Oct 2017Allergy Therapeutics is really exciting The allergy specialist has an exciting pipeline and significant catalysts ahead 05 October 2017|Great Ideas|by Lisa-Marie Janes Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Why Imperial Brands can recover XP Power buys new growth line > Issue: 05 Oct 2017 - Page 11 | Contents Next: XP Power buys new growth line Previous: Why Imperial Brands can recover Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Lisa-Marie Janes Issue Contents Editor's View Happy birthday to the new-look Shares Feature A stable for ‘Unicorns’ Rise in number of billionaires could aid GYG AIM superstar expands into insurance sector How to use stop losses to protect your portfolio How to invest in the electric vehicle revolution Are the rules for UK listed company takeovers about to get tougher? The power of Ted Baker’s brand Shares in Trinity could ‘triple in value’ says broker S&U has smart approach to motor finance Great Ideas Fill up on Greencore while the market is feasting elsewhere Allergy Therapeutics is really exciting Why Imperial Brands can recover XP Power buys new growth line Investment Trusts Don’t allow fees to become foes News EasyJet could benefit from Ryanair and Monarch problems Boost for housebuilders and real estate firms Our top picks of the year continue to outperform Land of the rising dividends Personal Finance How to switch to a stocks and shares ISA How much are YOU saving for retirement? Under The Bonnet Newly-listed retailer targets five-fold increase in sales Week Ahead Two large staffers to give updates on trading Will Friday the 13th be a horror show for Provident Financial? Will Marston’s follow Greene King with gloomy update?
